中文(繁體)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

antifungal/fatigue

鏈接已保存到剪貼板
頁 1 從 60 結果
CROSS-REFERENCE TO RELATED APPLICATIONS This application is the U.S. national stage of International Patent Application No. PCT/CN2011/079731, filed on Sep. 16, 2011, which claims the benefit of priority under 35 U.S.C. .sctn.119 from the following Chinese patent applications: Chinese Patent

Ergonomic therapeutic massage device

只有註冊用戶可以翻譯文章
登陸註冊
FIELD OF THE INVENTION This application discloses a device for body massage and in particular an ergonomic therapeutic massage device. BACKGROUND OF TEE INVENTION Massage is the physiologically and psychologically therapeutic manipulation of muscles, tendons, ligaments and cartilage, with the

Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever

只有註冊用戶可以翻譯文章
登陸註冊
This application includes as part of its disclosure a biological sequence listing which is being concurrently submitted through EFS-Web. Said biological sequence listing is contained in a file named "56256o1204.txt" which was created on Dec. 15, 2016, and has a size of 238,677 bytes, and is hereby

Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever

只有註冊用戶可以翻譯文章
登陸註冊
The sequence listing in the file named "67858o702005.txt" having a size of 238,525 bytes that was created Nov. 25, 2008 is hereby incorporated by reference in its entirety. BACKGROUND OF THE INVENTION Field of the Invention This invention is an extension of Applicants' prior invention disclosed in

Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever

只有註冊用戶可以翻譯文章
登陸註冊
This application claims priority to U.S. Ser. No. 12/153,612 filed May 21, 2008, U.S. Ser. No. 12/153,611 filed May 21, 2008, U.S. Ser. No. 12/124,723 filed May 21, 2008, provisional patent application No. 60/924,550, filed May 21, 2007, and provisional patent application No. 60/924,551, filed May

Antagonists of IL-6 to treat cachexia, weakness, fatigue, and/or fever

只有註冊用戶可以翻譯文章
登陸註冊
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention is an extension of Applicants' prior invention disclosed in the above-referenced patent applications relating to novel anti-IL-6 antibodies and novel therapies and therapeutic protocols using anti-IL-6 antibodies, preferably those

Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever

只有註冊用戶可以翻譯文章
登陸註冊
BACKGROUND OF THE INVENTION Field of the Invention This invention is an extension of Applicants' prior invention disclosed in the above-referenced patent applications relating to novel anti-IL-6 antibodies and novel therapies and therapeutic protocols using anti-IL-6 antibodies, preferably those
BACKGROUND OF THE INVENTION Field of the Invention This invention is an extension of Applicants' prior invention disclosed in the above-referenced patent applications relating to novel anti-IL-6 antibodies and novel therapies and therapeutic protocols using anti-IL-6 antibodies, preferably those
TECHNICAL FIELD The present invention relates to the field of therapeutic uses for erythropoietin, and more particularly, to treating subjects with a recombinant erythropoietin prepared from an Apa I human genomic DNA fragment, including recombinant erythropoietin expressed in transformed baby
FIELD OF THE INVENTION The present invention relates to methods for the treatment or prevention of fatigue associated with disordered sleep, for example, in multiple sclerosis, Fabry's disease, fibromyalgia, Parkinson's disease, or traumatic brain injury using cyclobenzaprine. The present invention
FIELD OF THE INVENTION The present invention relates to methods for the treatment or prevention of fatigue associated with disordered sleep, for example, in multiple sclerosis, Fabry's disease, fibromyalgia, Parkinson's disease, or traumatic brain injury using cyclobenzaprine. The present invention

Method of treating chronic fatigue syndrome

只有註冊用戶可以翻譯文章
登陸註冊
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to methods of treating individuals suffering from a variety of conditions wherein inhibiting reuptake of norepinephrine provides a benefit. In particular, the present invention relates to methods of treatment

Method of treating chronic fatigue syndrome

只有註冊用戶可以翻譯文章
登陸註冊
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to methods of treating individuals suffering from a variety of conditions wherein inhibiting reuptake of norepinephrine provides a benefit. In particular, the present invention relates to methods of treatment

Therapy platform anti-fatigue matting

只有註冊用戶可以翻譯文章
登陸註冊
TECHNICAL FIELD The present invention relates to the field of ergonomic and safety anti-fatigue matting. BACKGROUND OF THE INVENTION Work-related musculoskeletal disorders (MSD) result when there is a mismatch between the physical capacity of workers and the demands of the job. Musculoskeletal
The present invention relates to the use of alpha-1-antitrypsin for the preparation of effective drugs for the treatment of chronic fatigue syndrome. BACKGROUND Chronic fatigue syndrome (CFS) is a complex disorder, defined by the international Fukuda criteria (Fukuda K, et al., The chronic fatigue
加入我們的臉書專頁

科學支持的最完整的草藥數據庫

  • 支持55種語言
  • 科學支持的草藥療法
  • 通過圖像識別草藥
  • 交互式GPS地圖-在位置標記草藥(即將推出)
  • 閱讀與您的搜索相關的科學出版物
  • 通過藥效搜索藥草
  • 組織您的興趣並及時了解新聞研究,臨床試驗和專利

輸入症狀或疾病,並閱讀可能有用的草藥,輸入草藥並查看其所針對的疾病和症狀。
*所有信息均基於已發表的科學研究

Google Play badgeApp Store badge